Home/Filings/4/0001140361-17-003157
4//SEC Filing

CytomX Therapeutics, Inc. 4

Accession 0001140361-17-003157

$CTMXCIK 0001501989operating

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 1:52 PM ET

Size

5.6 KB

Accession

0001140361-17-003157

Insider Transaction Report

Form 4
Period: 2017-01-25
LADD CYNTHIA J
Senior VP and General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2017-01-25+84,00084,000 total
    Exercise: $11.94Exp: 2027-01-24Common Stock (84,000 underlying)
Footnotes (1)
  • [F1]1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Documents

1 file

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001501989

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 1:52 PM ET
Size
5.6 KB